MAMS_6 - A Novel Transcriptome-Informed Quantitative Real-Time PCR-Based Signature for Monitoring Tuberculosis Treatment Success

This article has 3 evaluations
Read the full article Related papers
This article on Sciety

Related articles

Related articles are currently not available for this article.